Target intelligence / Profile preview

Beta sliding clamp (β-clamp)

Target
β-clamp
Molecular classification
Enzyme cofactor (processivity factor), DNA replication factor, DNA repair protein, Other (ring-shaped hub protein associated with replicative polymerase)
01

Overview

The **Beta sliding clamp** (β-clamp) is a homodimeric, ring-shaped protein complex essential for processive DNA replication and DNA repair in bacteria, especially *Escherichia coli* and related species[4][5][8]. It acts as a central hub by encircling double-stranded DNA and tethering DNA polymerase III and other proteins required for efficient DNA synthesis and repair, thereby preventing dissociation from the DNA template[2][3][4]. The β-clamp interacts with numerous binding partners through a conserved clamp binding motif and coordinates multiple activities at the replication fork. Its evolutionary homolog in eukaryotes is proliferating cell nuclear antigen (PCNA), but the bacterial β-clamp is structurally a homodimer, whereas PCNA is a homotrimer. Due to its essential role and structural divergence from eukaryotic processivity factors, the β-clamp is under investigation as a novel antibacterial drug target, with some nonsteroidal anti-inflammatory drugs and small-molecule inhibitors demonstrating weak to moderate activity against *E. coli* β-clamp in vitro[5][6].

Other names
DNA sliding clampBeta clampDNA clampdnaN (in E. coli)Sliding clamp protein
02

Mechanism of action

Allosteric inhibition of protein-protein interactions (block protein binding pocket in β-clamp)[5][6]; Competitively block clamp-binding motif access (for DNA polymerases and repair factors)[6]

03

Biological functions

DNA replicationDNA repairCell cycle regulationProtein-protein scaffolding (processivity complex assembly)Other (tethers proteins to DNA, coordinates activities at DNA forks)
04

Disease associations

Infection (target for antibacterial therapy)Other (genome instability if dysfunctional; indirect relevance to cancer by analogy to eukaryotic PCNA)
05

Safety considerations

Targeting β-clamp disrupts essential DNA replication in bacteria, carrying a risk of cytotoxicity to bacteria but minimal off-target effects in humans due to structural differences (bacterial β-clamp vs. human PCNA)[5]Potential for development of bacterial resistance[5]
06

Interacting drugs

Non-steroidal anti-inflammatory drugs (e.g., carprofen, bromfenac, vedaprofen)[5]

2 more in the full profile.

Beyond the preview

Go deeper on Beta sliding clamp (β-clamp).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta sliding clamp (β-clamp).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call